載入...
OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution
Effective therapeutics for ovarian cancer continue to be urgently needed, particularly for chemotherapy-resistant cases. Here we present both a 3D-Matrigel culture-based expansion of our directed evolution method for generation of oncolytic virotherapies and two promising ovarian-cancer targeted onc...
Na minha lista:
| 發表在: | Mol Ther Oncolytics |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society of Gene & Cell Therapy
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5363728/ https://ncbi.nlm.nih.gov/pubmed/28345024 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2016.12.001 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|